Elboghdady Adel Aly, Ibrahim Mohamed Mohamed, Farahat Mohammed Farouk Abd El Azeem, Mohamed Mohamed Ali Mohamed, Atalla Emad Mohamed, Eltabakh Ahmed Abd Elkader, Ahmad Abdall Khalel, Diab Yasser Momamed Said, Khalil Gehad Fawzy Ali Ali, Metwally Mai Mohammed, El Makawy Alshaimaa Rabie, Ghit Adel Mohamed, Abo Eldahab Ibrahim Mohamed Ibrahim Mohamed, Elsayed Fadila Mamdouh
Ceska Gynekol. 2025;90(3):222-225. doi: 10.48095/cccg2025222.
It is to assess the ipsilateral and contralateral tubal patency by hysterosalpingography following salpingostomy and methotrexate therapy for tubal pregnancy.
The study was conducted between September 2021 and October 2023. It was conducted in the radiodiagnosis and obstetrics and gynecology departments of the Al-Hussin and Al-Azher university hospitals. Patients who had undergone salpingostomy or received methotrexate treatment were included in this research. Three months after being discharged, the individuals who were seeking for fertility were assessed again for Fallopian tube patency using hysterosalpingographs. Two groups of women participated in the study: group I (N = 50) received methotrexate treatment, while group II (N = 50) had undergone salpingostomy management.
The two groups (medical and surgery) did not vary statistically significantly in preserving tubal patency. Following methotrexate therapy, the ipsilateral tubal patency was 72%, and following surgical management, it was 74%. Furthermore, following methotrexate therapy, contralateral tubal patency was 92%, and 90% following salpingostomy.
The results point to comparable success rates with salpingostomy and methotrexate in preserving fallopian tube patency.
评估输卵管妊娠行输卵管造口术及甲氨蝶呤治疗后,通过子宫输卵管造影术评估同侧和对侧输卵管通畅情况。
本研究于2021年9月至2023年10月进行。在胡辛大学医院和爱资哈尔大学医院的放射诊断科及妇产科开展。本研究纳入了接受过输卵管造口术或接受甲氨蝶呤治疗的患者。出院三个月后,对有生育需求的个体再次使用子宫输卵管造影术评估输卵管通畅情况。两组女性参与了本研究:第一组(N = 50)接受甲氨蝶呤治疗,而第二组(N = 50)接受了输卵管造口术治疗。
两组(药物治疗组和手术治疗组)在保留输卵管通畅方面无统计学显著差异。甲氨蝶呤治疗后,同侧输卵管通畅率为72%,手术治疗后为74%。此外,甲氨蝶呤治疗后,对侧输卵管通畅率为92%,输卵管造口术后为90%。
结果表明,输卵管造口术和甲氨蝶呤在保留输卵管通畅方面成功率相当。